JP Stock MarketDetailed Quotes

4536 Santen Pharmaceutical

Watchlist
  • 1387.0
  • -7.0-0.50%
20min DelayNot Open Feb 14 15:30 JST
481.35BMarket Cap19.17P/E (Static)

Santen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
-0.85%76.37B
3.29%74.77B
8.22%301.97B
-0.15%79.13B
8.69%77.03B
15.83%73.42B
10.46%72.39B
4.80%279.04B
12.48%79.25B
5.71%70.87B
Cost of revenue
6.19%34.14B
6.60%32.01B
9.12%123.26B
15.11%31.66B
8.79%32.15B
7.04%29.43B
5.70%30.02B
2.99%112.95B
1.98%27.5B
-0.97%29.55B
Gross profit
-5.90%42.23B
0.95%42.77B
7.60%178.71B
-8.26%47.48B
8.61%44.88B
22.57%43.99B
14.11%42.37B
6.07%166.09B
19.00%51.75B
11.07%41.32B
Operating expense
-8.61%30.91B
-0.02%29.61B
-17.15%140.17B
0.90%45.09B
4.23%33.82B
-49.97%31.64B
2.85%29.62B
40.16%169.18B
31.52%44.69B
9.52%32.45B
Selling and administrative expenses
4.23%22.49B
1.49%21.38B
-4.91%91.53B
-12.92%26.78B
-7.03%21.58B
-3.32%22.11B
8.44%21.07B
13.91%96.26B
27.21%30.76B
12.26%23.21B
-General and administrative expense
4.23%22.49B
1.49%21.38B
-4.91%91.53B
-12.92%26.78B
-7.03%21.58B
-3.32%22.11B
8.44%21.07B
13.91%96.26B
27.21%30.76B
12.26%23.21B
Research and development costs
1.43%5.83B
-12.65%5.5B
-10.18%25.42B
8.96%7.21B
-22.49%5.75B
-14.08%6.16B
-11.24%6.3B
7.28%28.3B
-12.66%6.62B
14.71%7.42B
Depreciation and amortization
-10.49%2.13B
4.47%2.43B
-0.49%9.47B
4.14%2.39B
15.74%2.38B
-9.23%2.37B
-8.81%2.33B
-2.22%9.52B
-7.50%2.29B
-16.57%2.06B
-Depreciation
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Amortization
-10.49%2.13B
4.47%2.43B
-0.49%9.47B
4.14%2.39B
15.74%2.38B
-9.23%2.37B
-8.81%2.33B
-2.22%9.52B
-7.50%2.29B
-16.57%2.06B
Other operating expenses
-85.07%638M
60.81%357M
-60.39%15.3B
10.82%8.9B
13,253.13%4.27B
-93.77%1.91B
393.33%222M
3,309.44%38.63B
1,580.13%8.03B
-77.62%32M
Total other operating income
14.19%177M
-79.21%63M
-56.07%1.55B
-93.94%182M
-40.84%155M
--908M
-8.73%303M
237.87%3.52B
313.93%3B
125.86%262M
Operating profit
2.39%11.32B
3.18%13.16B
1,347.25%38.54B
-66.25%2.38B
24.63%11.06B
145.15%12.35B
52.99%12.75B
-108.61%-3.09B
-25.77%7.06B
17.14%8.87B
Net non-operating interest income (expenses)
168.20%148M
-66.55%295M
-215.61%-1.09B
-125.67%-1.42B
68.87%-217M
-19.29%-334M
-30.11%882M
-125.94%-346M
-173.71%-631M
-382.19%-697M
Non-operating interest income
-13.37%421M
-33.14%702M
36.34%1.57B
62.89%259M
13.55%486M
18.75%152M
-24.19%1.05B
-54.66%1.15B
-88.05%159M
-20.74%428M
Non-operating interest expense
-61.17%273M
142.26%407M
77.72%2.66B
113.04%1.68B
-37.51%703M
19.12%486M
36.59%168M
23.99%1.5B
66.32%790M
283.96%1.13B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
0
0
-220.70%-7.58B
-636.13%-4.65B
-103.45%-1.36B
-48.99%-809M
-46.64%-764M
-47.26%-2.36B
-50.96%-631M
-23.06%-667M
Special income (charges)
Other non-operating income (expenses)
Income before tax
20.94%11.47B
4.52%13.45B
615.16%29.87B
-163.60%-3.69B
26.30%9.48B
139.77%11.21B
41.81%12.87B
-116.28%-5.8B
-41.73%5.79B
3.15%7.51B
Income tax
29.69%2.83B
15.76%2.84B
-65.47%3.17B
-181.21%-3.81B
38.09%2.18B
335.69%2.34B
3.24%2.46B
8.98%9.18B
128.73%4.69B
-29.49%1.58B
Net income
18.33%8.64B
1.87%10.61B
278.22%26.7B
-88.87%123M
23.17%7.31B
130.86%8.86B
55.52%10.41B
-155.11%-14.98B
-86.00%1.11B
17.63%5.93B
Net income continuous operations
18.33%8.64B
1.87%10.61B
278.22%26.7B
-88.87%123M
23.17%7.31B
130.87%8.86B
55.52%10.41B
-155.11%-14.98B
-86.00%1.11B
17.63%5.93B
Noncontrolling interests
-81.48%-49M
-1,200.00%-26M
271.43%60M
945.45%93M
41.30%-27M
60.00%-4M
-106.25%-2M
-20.69%-35M
-145.83%-11M
-46M
Net income attributable to the company
18.56%8.69B
2.10%10.63B
278.23%26.64B
-97.40%29M
22.67%7.33B
130.89%8.87B
56.30%10.41B
-154.92%-14.95B
-85.82%1.12B
18.54%5.98B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
18.56%8.69B
2.10%10.63B
278.23%26.64B
-97.40%29M
22.67%7.33B
130.89%8.87B
56.30%10.41B
-154.92%-14.95B
-85.82%1.12B
18.54%5.98B
Gross dividend payment
Basic earnings per share
22.25%25.33
5.94%29.59
288.06%72.59
-86.96%0.33
33.76%20.72
132.56%24.6
66.35%27.93
-156.71%-38.6
-87.14%2.53
22.94%15.49
Diluted earnings per share
22.17%25.24
5.92%29.5
287.49%72.37
-87.35%0.32
33.64%20.66
132.45%24.52
66.07%27.85
-156.79%-38.6
-87.12%2.53
22.80%15.46
Dividend per share
0
0
3.13%33
6.25%17
0
0.00%16
0
0.00%32
0.00%16
0
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Dec 31, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue -0.85%76.37B3.29%74.77B8.22%301.97B-0.15%79.13B8.69%77.03B15.83%73.42B10.46%72.39B4.80%279.04B12.48%79.25B5.71%70.87B
Cost of revenue 6.19%34.14B6.60%32.01B9.12%123.26B15.11%31.66B8.79%32.15B7.04%29.43B5.70%30.02B2.99%112.95B1.98%27.5B-0.97%29.55B
Gross profit -5.90%42.23B0.95%42.77B7.60%178.71B-8.26%47.48B8.61%44.88B22.57%43.99B14.11%42.37B6.07%166.09B19.00%51.75B11.07%41.32B
Operating expense -8.61%30.91B-0.02%29.61B-17.15%140.17B0.90%45.09B4.23%33.82B-49.97%31.64B2.85%29.62B40.16%169.18B31.52%44.69B9.52%32.45B
Selling and administrative expenses 4.23%22.49B1.49%21.38B-4.91%91.53B-12.92%26.78B-7.03%21.58B-3.32%22.11B8.44%21.07B13.91%96.26B27.21%30.76B12.26%23.21B
-General and administrative expense 4.23%22.49B1.49%21.38B-4.91%91.53B-12.92%26.78B-7.03%21.58B-3.32%22.11B8.44%21.07B13.91%96.26B27.21%30.76B12.26%23.21B
Research and development costs 1.43%5.83B-12.65%5.5B-10.18%25.42B8.96%7.21B-22.49%5.75B-14.08%6.16B-11.24%6.3B7.28%28.3B-12.66%6.62B14.71%7.42B
Depreciation and amortization -10.49%2.13B4.47%2.43B-0.49%9.47B4.14%2.39B15.74%2.38B-9.23%2.37B-8.81%2.33B-2.22%9.52B-7.50%2.29B-16.57%2.06B
-Depreciation --0--0--0--0--0--0--0--0--0--0
-Amortization -10.49%2.13B4.47%2.43B-0.49%9.47B4.14%2.39B15.74%2.38B-9.23%2.37B-8.81%2.33B-2.22%9.52B-7.50%2.29B-16.57%2.06B
Other operating expenses -85.07%638M60.81%357M-60.39%15.3B10.82%8.9B13,253.13%4.27B-93.77%1.91B393.33%222M3,309.44%38.63B1,580.13%8.03B-77.62%32M
Total other operating income 14.19%177M-79.21%63M-56.07%1.55B-93.94%182M-40.84%155M--908M-8.73%303M237.87%3.52B313.93%3B125.86%262M
Operating profit 2.39%11.32B3.18%13.16B1,347.25%38.54B-66.25%2.38B24.63%11.06B145.15%12.35B52.99%12.75B-108.61%-3.09B-25.77%7.06B17.14%8.87B
Net non-operating interest income (expenses) 168.20%148M-66.55%295M-215.61%-1.09B-125.67%-1.42B68.87%-217M-19.29%-334M-30.11%882M-125.94%-346M-173.71%-631M-382.19%-697M
Non-operating interest income -13.37%421M-33.14%702M36.34%1.57B62.89%259M13.55%486M18.75%152M-24.19%1.05B-54.66%1.15B-88.05%159M-20.74%428M
Non-operating interest expense -61.17%273M142.26%407M77.72%2.66B113.04%1.68B-37.51%703M19.12%486M36.59%168M23.99%1.5B66.32%790M283.96%1.13B
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests 00-220.70%-7.58B-636.13%-4.65B-103.45%-1.36B-48.99%-809M-46.64%-764M-47.26%-2.36B-50.96%-631M-23.06%-667M
Special income (charges)
Other non-operating income (expenses)
Income before tax 20.94%11.47B4.52%13.45B615.16%29.87B-163.60%-3.69B26.30%9.48B139.77%11.21B41.81%12.87B-116.28%-5.8B-41.73%5.79B3.15%7.51B
Income tax 29.69%2.83B15.76%2.84B-65.47%3.17B-181.21%-3.81B38.09%2.18B335.69%2.34B3.24%2.46B8.98%9.18B128.73%4.69B-29.49%1.58B
Net income 18.33%8.64B1.87%10.61B278.22%26.7B-88.87%123M23.17%7.31B130.86%8.86B55.52%10.41B-155.11%-14.98B-86.00%1.11B17.63%5.93B
Net income continuous operations 18.33%8.64B1.87%10.61B278.22%26.7B-88.87%123M23.17%7.31B130.87%8.86B55.52%10.41B-155.11%-14.98B-86.00%1.11B17.63%5.93B
Noncontrolling interests -81.48%-49M-1,200.00%-26M271.43%60M945.45%93M41.30%-27M60.00%-4M-106.25%-2M-20.69%-35M-145.83%-11M-46M
Net income attributable to the company 18.56%8.69B2.10%10.63B278.23%26.64B-97.40%29M22.67%7.33B130.89%8.87B56.30%10.41B-154.92%-14.95B-85.82%1.12B18.54%5.98B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 18.56%8.69B2.10%10.63B278.23%26.64B-97.40%29M22.67%7.33B130.89%8.87B56.30%10.41B-154.92%-14.95B-85.82%1.12B18.54%5.98B
Gross dividend payment
Basic earnings per share 22.25%25.335.94%29.59288.06%72.59-86.96%0.3333.76%20.72132.56%24.666.35%27.93-156.71%-38.6-87.14%2.5322.94%15.49
Diluted earnings per share 22.17%25.245.92%29.5287.49%72.37-87.35%0.3233.64%20.66132.45%24.5266.07%27.85-156.79%-38.6-87.12%2.5322.80%15.46
Dividend per share 003.13%336.25%1700.00%1600.00%320.00%160
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
NISHIKAWA RUBBER
5161
4760 +46.91%
The Why How Do
3823
65 +41.30%
MIC
300A
1321 +29.38%
Amazia
4424
382 +26.49%
Itamiarts
168A
1481 +25.40%

See the daily top gainer.